The Role of Immunotherapy in the First-Line Treatment of Elderly Advanced Non-Small Cell Lung Cancer

The Role of Immunotherapy in the First-Line Treatment of Elderly Advanced Non-Small Cell Lung Cancer

Immune checkpoint inhibitors have changed the history of NSCLC treatment by becoming, alone or in combination with platinum-based chemotherapy, a mainstay of first-line therapy for advanced NSCLC. This increasingly dictates the identification of predictive biomarkers of response that can guide patie...

Full description

Bibliographic Details
Main Authors: Alessia Spagnuolo, Cesare Gridelli
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cancers
Subjects:
elderly patients
geriatric oncology
immune checkpoint inhibitors
immunotherapy
NSCLC
older patients
Online Access:https://www.mdpi.com/2072-6694/15/8/2319

Internet

https://www.mdpi.com/2072-6694/15/8/2319

Similar Items